DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Applicant’s response filed on 8/27/2026 is acknowledged and fully considered.
Status of Application, Amendments, And/Or Claims
The amendments of claim 63, 67-68, and 72-73, and the addition of claims 83-84 have been made of record.
Claims 64-66, 69-71 and 74-82 are cancelled.
Claims 63, 67-68,72-73 and 83-84 are pending and under consideration.
Drawings
Applicant’s filing of New corrected drawings in compliance with 37 CFR 1.121(d) are acknowledged and fully considered.
Claim Rejections - 35 USC § 102-withdrawn
The rejection of claim(s) 63-73 under 35 U.S.C. 102(a)(1) as being anticipated by Kurihara et al. (IDS, WO 2020/148913) is withdrawn in view of applicants’ amendments to claims 63, 67-68, and 72-73 and the cancellation of claims 64-66, 69-71 and 74-82. Additionally, applicants’ arguments that Kurihara is available for less than one year has been found persuasive
Claim Rejections - 35 USC § 112-scope of enablement-maintained
The following is a quotation of the first paragraph of 35 U.S.C. 112(a):
(a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention.
The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112:
The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
Claims 63, 67-68,72-73 remain rejected and newly added claims 83-84 under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, because the specification, while being enabling for a method of treating a retinal disease in a subject in need thereof comprising administering an effective amount of a light absorbing substance wherein the substance is a chimeric rhodopsin, does not reasonably provide enablement for a method of preventing retinal disease in a subject in need thereof comprising an effective amount of any light absorbing substance. The specification does not enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and/or use the invention commensurate in scope with these claims.
Applicants argue that they have now amended the claims to a method of treating or preventing a retinal disease in a subject in need thereof comprising administering an effective amount of a light absorbing substance to the subject and therefore, it would be allowable.
Applicants’ arguments have been fully considered but they are not persuasive because the claims now read on “preventing any retinal disease” comprising administering an effective amount of a light absorbing substance to the subject which is not enabled because the specification only enabled for a method of treating but not preventing any retinal disease. Applicant may want to delete the term “preventing” to overcome with the rejection.
Double Patenting-withdrawn
The rejection of claims 63-65, 70-71 and 73 on the ground of nonstatutory double patenting as being unpatentable over claims 1,12 and 14-16 of U.S. Patent No. 11,771,741 is withdrawn in view of applicant’s amendments to claim 63 and the cancellation of claims 64-65, 70-71.
The provisional rejection of claims 63-65, and 67-73 on the ground of nonstatutory double patenting as being unpatentable over claims 43-49, and 51 of copending Application No. 19239,026 is withdrawn in view of applicant’s amendments to claim 63 and the cancellation of claims 64-65, 70-71.
The provisional rejection of claims 63-65, 68-71 and 73 on the ground of nonstatutory double patenting as being unpatentable over claims 1, 7, 13, 19, 26, 28, 33-36 of copending Application No. 17/642,923 is withdrawn in view of applicant’s amendments to claim 63 and the cancellation of claims 64-65, 70-71.
Conclusion
No claim is allowed.
Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to GYAN CHANDRA whose telephone number is (571)272-2922. The examiner can normally be reached Mon-Friday 8:30AM-5:00P.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Vanessa Ford can be reached at 571-272-0857. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/GYAN CHANDRA/Primary Examiner, Art Unit 1674